Alexa FluorRTM 700 anti-human CD19 [HIB19] and 2 more items

The University of Virginia awarded contract A207_PO-0456540-V2 to BioLegend Inc. on July 15, 2026, for the procurement of fluorescent-labeled monoclonal antibodies utilized in flow cytometry and immunological research applications. The contract, valued at $625, encompasses three distinct line items totaling one unit each, all designated for delivery to Trudy D Robinson at the University of Virginia in Virginia. The purchased reagents include Alexa Fluor 700 anti-human CD19 [HIB19] at $187.60, Alexa Fluor 700 anti-human CD11b [ICRF44] at $119.70, and Brilliant Violet 605 anti-human CD4 [OKT4] at $318.00.

These biological research reagents serve as essential tools for identifying and analyzing specific cell surface markers in human blood and tissue samples. The contract represents a standard procurement of laboratory supplies by an academic research institution and does not specify a defined period of performance beyond the award date. As a straightforward purchase order, this award reflects routine acquisition of consumable scientific materials required for ongoing research operations at the University of Virginia.